REDWOOD CITY, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), announced today that it has received written communication from the NASDAQ Listing Qualifications Panel that the Company has demonstrated compliance with NASDAQ's Minimum Bid Price Requirement, as evidenced by a closing bid price of $1.00 or more for a minimum of ten consecutive trading days. Accordingly, the NASDAQ Hearings Panel has determined that the Company's shares will continue to be listed on The NASDAQ Capital Market.
